MetaADEDB: ADE

MetaADEDB 2.0 @ LMMD

Hemangiosarcoma

(UMLS:C0018923)

Definition:: A rare malignant neoplasm characterized by rapidly proliferating, extensively infiltrating, anaplastic cells derived from blood vessels and lining irregular blood-filled or lumpy spaces. (Stedman, 25th ed)
UMLS ID:: C0018923
MeSH ID:: D006394

Classification:

Name:

Neoplasms
MeSH Tree Number(s):: C04.557.450.795.390|C04.557.645.390

Synonym(s)

Hemangiosarcoma

Angiosarcoma

HEMANGIOSARCOMA, MALIGNANT

Haemangioendothelial sarcoma

Haemangioendothelioma, malignant

Haemangiosarcoma

Hemangioendothelial sarcoma

Hemangioendothelioma, malignant

Associated Drug(s)

	Name	Reference(s)	Data Source
1	1,2-Dimethylhydrazine	2737135	CTD
2	1,3-butadiene	2208121 10930038	CTD
3	1-(2-hydroxyethyl)-1-nitrosourea	3401843	CTD
4	1-(4-(1-((E)-4-cyclohexyl-3-trifluoromethylbenzyloxyimino)-ethyl)-2-ethylbenzyl)-azetidine-3-carboxylic acid	29556671	CTD
5	2-Acetylaminofluorene	6705139	CTD
6	2-nitrotoluene	12087420 12504353 13678655	CTD
7	4-chloroaniline	15200160	CTD
8	4-nitroaniline	15200160	CTD
9	Aminopyrine	168160	CTD
10	Arsenicals	7586214	CTD
11	Diethylstilbestrol	567256	CTD
12	Doxorubicin	15692506	CTD
13	Fenretinide	28973697	CTD
14	Methylenebis(chloroaniline)	512554	CTD
15	Paclitaxel	9774950	CTD
16	Pentachlorophenol	15200160	CTD
17	Pentosan Sulfuric Polyester	28973697	CTD
18	Phenelzine	572729 943238	CTD
19	Polyvinyl Chloride	View details 7586214 11217710 12211074 12762079 12828392 12958735 15989139 15999577	CTD
20	Pregabalin	22539615 29556671	CTD
21	Sodium Nitrite	168160	CTD
22	Thorium Dioxide	7586214	CTD
23	Troglitazone	View details 17569031 18465119 19285096 21684317 21937740 28973697	CTD
24	Urethane	18465119	CTD
25	azoxyethane	3965154	CTD
26	chloroacetaldehyde	10626228	CTD
27	n-butoxyethanol	15200160 20153399 29556671	CTD
28	quinoline	598648	CTD
29	riddelliine	View details 12844193 12927348 13678655 15127726 15488633 20737008	CTD
30	tetrafluoroethylene	15200160	CTD
31	vinyl fluoride	9073601	CTD

Similar ADE(s)

	Name	Semantic Similarity
1	Chondrosarcoma	50.4%
2	leiomyosarcoma	50.4%
3	liposarcoma	50.4%
4	synovial sarcoma	50.4%
5	Clear Cell Sarcoma of Soft Tissue	50.4%
6	Alveolar Soft Part Sarcoma	50.4%
7	Carcinosarcoma	49.2%
8	lymphangiosarcoma	49.2%
9	Fibrosarcoma	46.2%
10	Osteosarcoma	46.2%
11	Malignant Fibrous Histiocytoma	44%
12	Sarcoma, Myeloid	43.9%
13	Phyllodes Tumor	42.4%
14	Desmoplastic Small Round Cell Tumor	42.4%
15	Angiokeratoma	40.7%
16	Hemangioma	40.7%
17	hemangiopericytoma	40.7%
18	Angiofibroma	40.7%
19	Rhabdomyosarcoma	38.7%
20	Angiomyolipoma	37.4%
21	leukemia	37.1%
22	Neoplasms, Germ Cell and Embryonal	37.1%
23	Neoplasms, Glandular and Epithelial	37.1%
24	Germ Cell Cancer	37.1%
25	Carcinoma 256, Walker	37%
26	Dermatofibrosarcoma	36.6%
27	Dermatofibrosarcoma Protuberans	36.6%
28	Neuroectodermal Tumors	34.7%
29	Meningioma	33.8%
30	Neoplasms, Neuroepithelial	33.3%
31	Gliomatosis cerebri	33.3%
32	Sarcoma, Experimental	33.1%
33	Alveolar rhabdomyosarcoma	32.9%
34	Sarcoma 180	30.2%
35	Hemangioendothelioma	29.3%
36	melanoma	29.2%
37	Giant Cell Tumor of Bone	29%
38	Histiocytic Disorders, Malignant	27.7%
39	Endometrial Stromal Sarcoma	27.4%
40	Medulloblastoma	26.3%
41	Neurofibrosarcoma	26.3%
42	Adenoma, Acidophil	25.2%
43	Ganglioneuroma	25.2%
44	Glioma	25.2%
45	Malignant Glioma	25.2%
46	Lipoma	25%
47	Myoma	25%
48	Myxoma	25%
49	Angiolipoma	25%
50	Myelolipoma	25%
51	Neoplasms, Bone Tissue	25%
52	Neoplasms, Fibrous Tissue	25%
53	Smooth Muscle Tumor	25%
54	Chondroma	25%
55	Enchondroma	25%
56	Adenofibroma	24.6%
57	Fibroadenoma	24.6%
58	Basal cell carcinoma	24.4%
59	Carcinoma, Papillary	24.4%
60	Squamous cell carcinoma	24.4%
61	Craniopharyngioma	24.4%
62	Cystadenoma	24.4%
63	Mesothelioma	24.4%
64	Neuroectodermal Tumor, Melanotic	24.4%
65	Neuroendocrine Tumors	24.4%
66	Carcinoma, Basal Cell	24.4%
67	Hemangioblastoma	23.8%
68	Leukemia, Plasma Cell	23.5%
69	Carcinoid Tumor	23.2%
70	Neurilemmoma	23.2%
71	Hutchinson's Melanotic Freckle	23.2%
72	Melanoma, Amelanotic	23.2%
73	Adenoma	23.1%
74	Ameloblastoma	23.1%
75	Carcinoma	23.1%
76	Chordoma	23.1%
77	Lymphangioma	23.1%
78	Mesenchymoma	23.1%
79	Nevus	23.1%
80	Teratoma	23.1%
81	Hepatoblastoma	23.1%
82	Mixed Tumor, Mullerian	23.1%
83	Germinoma	23.1%
84	Teratocarcinoma	23.1%
85	Epithelioma	23.1%
86	Composite Lymphoma	23%
87	Hamartoma	22.4%
88	Neoplasms, Hormone-Dependent	22.4%
89	Neoplasms, Multiple Primary	22.4%
90	Paraneoplastic Syndromes	22.4%
91	Precancerous Conditions	22.4%
92	Neoplasms, Second Primary	22.4%
93	Lymphoma	22.1%
94	Melanoma, Experimental	21.9%
95	Cystadenocarcinoma	21.9%
96	Mucoepidermoid Carcinoma	21.9%
97	Carcinoma, Ehrlich Tumor	21.7%
98	Dermoid Cyst	21.7%
99	Carcinoma, Lewis Lung	21.7%
100	Trophoblastic Neoplasms	21.5%
101	Leukemia, Experimental	21.3%
102	Astrocytoma	21.2%
103	Ependymoma	21.2%
104	oligodendroglioma	21.2%
105	Ganglioglioma	21.2%
106	gliosarcoma	21.2%
107	Anaplastic astrocytoma	21.2%
108	Anaplastic Oligodendroglioma	21.2%
109	Lymphangioleiomyomatosis	20.5%
110	Malignant Carcinoid Syndrome	20.2%
111	fibroma	19.5%
112	Fibromatosis	19.5%
113	Osteoblastoma	19.5%
114	Osteoma	19.5%
115	Rhabdomyoma	19.5%
116	Chondromatosis	19.5%
117	Bowen's Disease	19.4%
118	Paraganglioma	19.4%
119	Glioblastoma	19.2%
120	Neuroblastoma	19.2%
121	Glioblastoma Multiforme	19.2%
122	Choriocarcinoma	18.4%
123	Carcinoma, Lobular	18.4%
124	Ganglioneuroblastoma	18.2%
125	Leukemia L1210	18%
126	Leukemia P388	18%
127	Acanthoma	18%
128	Sturge-Weber Syndrome	18%
129	Leukemia, Radiation-Induced	18%
130	Hemangioma, Cavernous	17.6%
131	Plasmacytoma	17.4%
132	Malignant histiocytosis	17.2%
133	Histiocytic sarcoma	17.2%
134	Thymoma	17.1%
135	Pheochromocytoma	16.9%
136	Cyst	16.8%
137	Neoplastic Processes	16.8%
138	Neoplastic Syndromes, Hereditary	16.8%
139	Pregnancy Complications, Neoplastic	16.8%
140	Fibromatosis, Aggressive	16.7%
141	Fibromatosis, Abdominal	16.7%
142	Neoplasms, Experimental	16.5%
143	Adenocarcinoma	16.3%
144	Carcinoma in Situ	16.3%
145	Carcinoma, Transitional Cell	16.3%
146	Dysgerminoma	16.3%
147	Neuroma	16.3%
148	Papilloma	16.3%
149	Pseudomyxoma Peritonei	16.3%
150	Seminoma	16.3%
151	Papillomatosis	16.3%
152	Adenomatosis, Pulmonary	16.3%
153	Adenomatous Polyps	16.3%
154	Carcinoma, Large Cell	16.3%
155	Carcinoma, Small Cell	16.3%
156	Retinoblastoma	16.1%
157	Carcinoid Heart Disease	15.8%
158	Mastocytosis	15.3%
159	Gastrointestinal Stromal Tumors	15.1%
160	Hemangiosarcoma	14.8%
161	Mastocytoma	14.7%
162	Mastocytosis, Systemic	14.6%
163	Multiple Endocrine Neoplasia	14.1%
164	Hodgkin Disease	13.7%
165	Lymphoma, Non-Hodgkin	13.7%
166	Neoplasms, Radiation-Induced	13.2%
167	Sarcoma	13.2%
168	Adenoid Cystic Carcinoma	13%
169	Adenocarcinoma, Clear Cell	13%
170	Cholangiocarcinoma	13%
171	Cervical Intraepithelial Neoplasia	13%
172	Lymphoma, Extranodal NK-T-Cell	13%
173	Lymphomatoid Granulomatosis	12.5%
174	Abdominal Neoplasms	12.4%
175	Erythroplasia	12.4%
176	Follicular cyst	12.4%
177	Head and Neck Neoplasms	12.4%
178	Mucocele	12.4%
179	Pilonidal Cyst	12.4%
180	Soft Tissue Neoplasms	12.4%
181	Thoracic Neoplasms	12.4%
182	Thyroglossal Cyst	12.4%
183	Synovial Cyst	12.4%
184	Aberrant Crypt Foci	12.4%
185	Paraneoplastic Encephalomyelitis	12.2%
186	Leukemia, Myelomonocytic, Chronic	12.2%
187	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	12.2%
188	Mammary Neoplasms, Experimental	12%
189	Acoustic Neuroma	12%
190	Nephroblastoma	11.8%
191	Carcinoma, Pancreatic Ductal	11.8%
192	Basal Cell Nevus Syndrome	11.6%
193	Primary amyloidosis	11.5%
194	Klatskin Tumor	11.3%
195	Hydatidiform Mole	11%
196	Hepatocellular Adenoma	10.9%
197	Optic Nerve Glioma	10.8%
198	Vipoma	10.3%
199	Dupuytren Contracture	10.3%
200	Tuberous Sclerosis	10.1%
201	Mesoblastic Nephroma	10.1%
202	Urticaria Pigmentosa	10.1%
203	Leukemia, T-Cell	9.7%
204	Leukemia, B-Cell	9.7%
205	Digestive System Neoplasms	9.7%
206	Endocrine Gland Neoplasms	9.7%
207	Eye Neoplasms	9.7%
208	Nervous System Neoplasms	9.7%
209	neurofibroma	9.7%
210	Leukemia, Myeloid, Chronic-Phase	9.7%
211	Lymphoma, Follicular	9.7%
212	T-Cell Lymphoma	9.7%
213	Mantle cell lymphoma	9.7%
214	Bone neoplasms	9.4%
215	Leukoplakia	9.4%
216	Lymphocele	9.4%
217	Pancreatic Cyst	9.4%
218	Skin Neoplasms	9.4%
219	Hematologic Neoplasms	9.4%
220	Prolactinoma	9.3%
221	Growth Hormone-Secreting Pituitary Adenoma	9.3%
222	Barrett Esophagus	9.2%
223	Breast Cyst	9.2%
224	Actinic keratosis	9.2%
225	Mediastinal Cyst	9.2%
226	Neoplasm Invasiveness	9.2%
227	Neoplasm Metastasis	9.2%
228	Neoplasm Recurrence, Local	9.2%
229	Parovarian Cyst	9.2%
230	Pericardial Cyst	9.2%
231	Splenic Neoplasms	9.2%
232	Thymic Cyst	9.2%
233	Carcinogenesis	9.2%
234	Myxoid cyst	9.2%
235	Metastasis	9.2%
236	Multiple Endocrine Neoplasia Type 1	8.9%
237	Waldenstrom Macroglobulinemia	8.6%
238	Multiple Myeloma	8.6%
239	granulosa cell tumor	8.1%
240	Carcinoma, Ovarian Epithelial	8.1%
241	insulinoma	8%
242	Parathyroid Neoplasms	7.9%
243	Peritoneal Neoplasms	7.9%
244	Thyroid Neoplasm	7.9%
245	Thyroid carcinoma	7.9%
246	Adenomatous Polyposis Coli	7.8%
247	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	7.7%
248	Leukemia, Large Granular Lymphocytic	7.7%
249	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	7.7%
250	Retroperitoneal Neoplasms	7.7%
251	Lymphoma, T-Cell, Cutaneous	7.7%
252	Lymphoma, AIDS-Related	7.7%
253	Enteropathy-Associated T-Cell Lymphoma	7.7%
254	Primary Effusion Lymphoma	7.7%
255	Liver Neoplasms, Experimental	7.6%
256	Gastrinoma	7.4%
257	Glucagonoma	7.4%
258	Adrenocortical carcinoma	7.4%
259	Corpus Luteum Cyst	7.3%
260	Ovarian Cysts	7.3%
261	Leydig Cell Tumor	6.9%
262	Pancreatic Neoplasm	6.8%
263	Tracheal Neoplasms	6.7%
264	Mycosis Fungoides	6.7%
265	Lymphomatoid Papulosis	6.7%
266	Plasmablastic lymphoma	6.7%
267	Nasopharyngeal carcinoma	6.6%
268	Leukoplakia, Oral	6.6%
269	Paraneoplastic Cerebellar Degeneration	6.6%
270	Renal Cell Carcinoma	6.4%
271	Papillary Renal Cell Carcinoma	6.4%
272	Choledochal Cyst	6.2%
273	Carcinoma, Endometrioid	6.2%
274	Peutz-Jeghers Syndrome	6.1%
275	Mouth Neoplasms	5.9%
276	Central Nervous System Neoplasms	5.9%
277	Vascular Neoplasms	5.9%
278	Thymus Neoplasms	5.9%
279	Denys-Drash Syndrome	5.8%
280	Genital Neoplasms, Female	5.8%
281	Pancreatic Pseudocyst	5.8%
282	Lymphatic Metastasis	5.7%
283	Neoplasms, Unknown Primary	5.7%
284	Leukemic Infiltration	5.7%
285	Breast Neoplasms, Male	5.7%
286	Neoplasm Micrometastasis	5.7%
287	Triple Negative Breast Neoplasms	5.7%
288	Esophageal Neoplasms	5.7%
289	Limbic Encephalitis	5.6%
290	Burkitt Lymphoma	5.5%
291	Thyroid Nodule	5.5%
292	Lambert-Eaton Myasthenic Syndrome	5%
293	Testicular Neoplasms	5%
294	Sezary Syndrome	4.8%
295	Adrenal Gland Neoplasms	4.8%
296	Gastrointestinal Neoplasms	4.8%
297	Genital Neoplasms, Male	4.8%
298	Liver neoplasms	4.8%
299	Uveal Neoplasms	4.8%
300	Urologic Neoplasms	4.7%
301	Sebaceous Gland Neoplasms	4.6%
302	Spinal Neoplasms	4.6%
303	Bone Marrow Neoplasms	4.6%
304	Polycystic Ovary Syndrome	4.6%
305	Opsoclonus-Myoclonus Syndrome	4.4%
306	Meningeal Neoplasms	4.1%
307	Myelitis, Transverse	3.9%
308	Nose Neoplasms	3.8%
309	Xeroderma Pigmentosum	3.7%
310	Palatal Neoplasms	3.7%
311	Ear Neoplasms	3.4%
312	Eyelid Neoplasms	3.4%
313	Lung Neoplasms	3.4%
314	Pleural Neoplasms	3.4%
315	Pituitary Adenoma	3.4%
316	Pituitary Neoplasms	3.4%
317	ovarian neoplasm	3.3%
318	Cell Transformation, Viral	3.3%
319	Brain Neoplasms	3.3%
320	Salivary Gland Neoplasms	3.3%
321	Spinal Cord Neoplasms	3.3%
322	Tongue Neoplasms	3.3%
323	Uterine Neoplasms	3.2%
324	Vaginal Neoplasms	3.2%
325	Vulvar Neoplasms	3.2%
326	Uterine Cancer	3.2%
327	Meningeal Carcinomatosis	3.2%
328	Fallopian Tube Neoplasms	3.2%
329	Pharyngeal Neoplasms	2.8%
330	Central Nervous System Cysts	2.8%
331	Bile Duct Neoplasms	2.7%
332	gallbladder neoplasm	2.7%
333	Intestinal Neoplasms	2.7%
334	Penile Neoplasms	2.7%
335	Prostatic Neoplasms	2.7%
336	Stomach Neoplasms	2.7%
337	Polycythemia Vera	2.7%
338	Bronchial Neoplasms	2.7%
339	Multiple Pulmonary Nodules	2.6%
340	Supratentorial Neoplasms	2.6%
341	Endometrial Neoplasms	2.6%
342	Zollinger-Ellison syndrome	2.6%
343	Laryngeal neoplasm	2.5%
344	Bladder Neoplasm	2.3%
345	Kidney Neoplasm	2.3%
346	Ureteral Neoplasms	2.3%
347	Urethral Neoplasms	2.3%
348	Brain Stem Neoplasms	2.2%
349	Hypopharyngeal Neoplasms	2.2%
350	Pleural Effusion, Malignant	2.2%
351	Hypopharyngeal Cancer	2.2%
352	Parotid Neoplasms	2.2%
353	Prostatic Neoplasms, Castration-Resistant	2.2%
354	Nelson Syndrome	2.1%
355	Choroid Plexus Papilloma	2.1%
356	Tonsillar Neoplasms	1.9%
357	Cerebellar Neoplasms	1.9%
358	Cecal Neoplasms	1.8%
359	Duodenal Neoplasms	1.8%
360	Nasopharyngeal Neoplasms	1.6%
361	Colorectal Neoplasms	1.6%
362	Radicular Cyst	1.6%
363	Appendiceal Neoplasms	1.6%
364	Colonic Neoplasms	1.6%
365	Rectal Neoplasms	1.6%
366	Paranasal Sinus Neoplasms	1.5%
367	Anus Neoplasms	1.3%
368	Sigmoid Neoplasms	1.3%
369	Maxillary Sinus Neoplasms	1.3%

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234